|
Volume
25 Number 5
15 March 2023
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
25, Year 2023 >
Number
5, 15 March
|
|
|
|
|
|
Yağcı-Küpeli
B, Pehlivan D.
Bevacizumab-containing
regimens for children with relapsed or refractory tumors.
Indian
J Cancer. 2022 Jun 29→.
doi: 10.4103/ijc.IJC_907_20(?). PMID: 36861699→.
Observational study. ˍ
|
|
|
|
Weng G, Ermiş E, Maragkou T, Krcek R, Reinhardt P, Zubak I,
Schucht P, Wiest R, Slotboom J, Radojewski P.
Accurate
prediction of isocitrate dehydrogenase -mutation status of gliomas
using SLOW-editing magnetic resonance spectroscopic imaging at 7 T
MR.
Neurooncol
Adv. 2023 Jan 3;5(1):vdad001→.
doi: 10.1093/noajnl/vdad001→.
PMID: 36875625→.
Observational study. ˍ
|
|
|
|
Bosio A,
Cerretti G, Padovan M, Caccese M, Denaro L, Chioffi F, Della Puppa
A, Aldegheri V, Guarneri V, Zagonel V, Lombardi G.
Metronomic
Temozolomide in Heavily Pretreated Patients With Recurrent
Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life
Mono-Institutional Study.
Clin
Oncol (R Coll Radiol). 2023 Feb 2:S0936-6555(23)00017-1→.
doi: 10.1016/j.clon.2023.01.012→.
PMID: 36858930→.
Observational study. ˍ
|
|
|
|
Mou B, Cruz-Lim EM.
Recurrent
Extraneural Metastatic Medulloblastoma in an Adult Presenting With
a Superscan and Treated With Radium-223.
Cureus.
2023 Feb 7;15(2):e34732→.
doi: 10.7759/cureus.34732→.
PMID: 36909024→.
Case report. ˍ
|
|
|
|
Uetani H, Azuma M, Khant ZA, Watanabe Y, Kudo K, Kadota Y,
Yokogami K, Takeshima H, Kuroda JI, Shinojima N, Hamasaki T,
Mukasa A, Hirai T.
Importance of Age
and Noncontrast-Enhancing Tumor as Biomarkers for Isocitrate
Dehydrogenase-Mutant Glioblastoma: A Multicenter Study.
J
Comput Assist Tomogr. 2023 Feb 10→.
doi: 10.1097/RCT.0000000000001456→.
PMID: 36877775→.
Observational study. ˍ
|
|
|
|
Renovanz M, Kurz SC, Rieger J, Walter B, Becker H, Hille H,
Bombach P, Rieger D, Grosse L, Häusser L, Skardelly M, Merk
DJ, Paulsen F, Hoffmann E, Gani C, Neumann M, Beschorner R, Rieß
O, Roggia C, Schroeder C, Ossowski S, Armeanu-Ebinger S, Gschwind
A, Biskup S, Schulze M, Fend F, Singer S, Zender L, Lengerke C,
Brucker SY, Engler T, Forschner A, Stenzl A, Kohlbacher O, Nahnsen
S, Gabernet G, Fillinger S, Bender B, Ernemann U, Öner Ö,
Beha J, Malek HS, Möller Y, Ruhm K, Tatagiba M, Schittenhelm
J, Bitzer M, Malek N, Zips D, Tabatabai G.
Clinical
outcome of biomarker-guided therapies in adult patients with
tumors of the nervous system.
Neurooncol
Adv. 2023 Feb 14;5(1):vdad012→.
doi: 10.1093/noajnl/vdad012→.
PMID: 36915613→.
Interventional study. ˍ
|
|
|
|
Bărăian
AI, Iacob BC, Sorițău O, Tomuță I, Tefas LR,
Barbu-Tudoran L, Șușman S, Bodoki E.
Ruxolitinib-Loaded
Imprinted Polymeric Drug Reservoir for the Local Management of
Post-Surgical Residual Glioblastoma Cells.
Polymers
(Basel). 2023 Feb 15;15(4):965→.
doi: 10.3390/polym15040965→.
PMID: 36850247→.
Laboratory investigation. ˍ
|
|
|
|
Goldsmith HS.
Introduction of
chemotherapy by omentum for a glioblastoma WHO-IV.
Surg
Neurol Int. 2023 Feb 17;14:59→.
doi: 10.25259/SNI_1080_2022→.
PMID: 36895220→.
Editorial. ˍ
|
|
|
|
Shen F, Li J, Liu F, Sun N, Qiu X, Ding W, Sun X.
The
efficacy and adverse effects of anlotinib in the treatment of
high-grade glioma: A retrospective analysis.
Front
Oncol. 2023 Feb 17;13:1095362→.
doi: 10.3389/fonc.2023.1095362→.
PMID: 36874124→.
Observational study. ˍ
|
|
|
|
Bigagli E, Agostiniani S, Pugi A, Rombi B, Tornaboni EE, Censullo
ML, Gori CG, Pavone R, Sardi I.
Unforeseen
cytomegalovirus retinopathy following high dose thiotepa and
proton irradiation in a pediatric patient with high-risk
medulloblastoma: A case report.
Front
Pediatr. 2023 Feb 21;11:1145941→.
doi: 10.3389/fped.2023.1145941→.
PMID: 36896395→.
Case report. ˍ
|
|
|
*
|
Liu Y, Li L, Hu H, Yang J, Zhang X, Chen L, Chen F, Hao S, Li W,
Huang G.
Association between
preoperative hematocrit and postoperative 30-day mortality in
adult patients with tumor craniotomy.
Front
Neurol. 2023 Feb 21;14:1059401→.
doi: 10.3389/fneur.2023.1059401→.
PMID: 36895901→.
Observational study. ˍ
|
|
|
|
Ladenhauf VK, Galijasevic M, Kerschbaumer J, Freyschlag CF,
Nowosielski M, Birkl-Toeglhofer AM, Haybaeck J, Gizewski ER,
Mangesius S, Grams AE.
Peritumoral ADC
Values Correlate with the MGMT Methylation Status in Patients with
Glioblastoma.
Cancers
(Basel). 2023 Feb 22;15(5):1384→.
doi: 10.3390/cancers15051384→.
PMID: 36900177→.
Observational study. ˍ
|
|
|
|
Krishnatry R,
Mani S, Manjali JJ, Rane PP, Chatterjee A, Goda JS, Janu A, Sahu
A, Gupta T, Jalali R.
Institutional
Patterns of Care of Diffuse Intrinsic Pontine Glioma.
Neurol
India. 2023 Feb 24;71(1):72-78→.
doi: 10.4103/0028-3886.370459(?). PMID: 36861577→.
Observational study. ˍ
|
|
|
|
Malhotra KP,
Kaif M, Malhotra HS, Husain N.
A
Novel Case of Primary Conus Medullaris Epithelioid Glioblastoma
with Gliosarcomatous Differentiation.
Neurol
India. 2023 Feb 24;71(1):132-134→.
doi: 10.4103/0028-3886.370454(?) PMID: 36861587→.
Case report. ˍ
|
|
|
|
Sangeeta T,
Prerana R, Kumar AA, Amarnath J.
Simultaneous
Amino Acid PET/MRI - An Opportunity to Assess True Response in
Recurrent High-Grade Glioma after Antiangiogenic Therapy.
Neurol
India. 2023 Feb 24;71(1):158-159→.
doi: 10.4103/0028-3886.370455(?) PMID: 36861599→.
Letter to the editor, Case report. ˍ
|
|
|
*
|
Shahab SW, Schniederjan M, Vega JV, Little S, Reisner A, MacDonald
T, Aguilera D.
Case report: ATIC-ALK
fusion in infant-type hemispheric glioma and response to
lorlatinib.
Front
Oncol. 2023 Feb 24;13:1123378→.
doi: 10.3389/fonc.2023.1123378→.
PMID: 36910660→.
Case report. ˍ
|
|
|
|
Aftahy AK, Butenschoen VM, Hoenikl
L, Liesche-Starnecker F, Wiestler B, Schmidt-Graf F, Meyer B,
Gempt J.
A
rare case of H3K27-altered diffuse midline glioma with multiple
osseous and spinal metastases at the time of diagnosis.
BMC
Neurol. 2023 Feb 28;23(1):87→.
doi: 10.1186/s12883-023-03135-4→.
PMID: 36855102→.
Case
report. ˍ
|
|
|
|
Tringale KR, Wolden SL, Karajannis M, Haque S, Pasquini L,
Yildirim O, Rosenblum M, Benhamida JK, Cheung NK, Souweidane M,
Basu EM, Pandit-Taskar N, Zanzonico PB, Humm JL, Kramer
K.
Outcomes of intraventricular
131-I-omburtamab and external beam radiotherapy in patients with
recurrent medulloblastoma and ependymoma.
J
Neurooncol. 2023 Feb 28→.
doi: 10.1007/s11060-022-04235-w→.
PMID: 36853490→.
Interventional study. ˍ
|
|
|
|
|
|
Królicki
L, Kunikowska J, Bruchertseifer F, Kuliński R, Pawlak D,
Koziara H, Rola R, Morgenstern A, Merlo A.
Locoregional
Treatment of Glioblastoma With Targeted α Therapy:
[213Bi]Bi-DOTA-Substance P Versus [225Ac]Ac-DOTA-Substance
P-Analysis of Influence Parameters.
Clin
Nucl Med. 2023 Mar 1→.
doi: 10.1097/RLU.0000000000004608→.
PMID: 36854309→.
Observational study˰ ˍ
|
|
|
|
Bergengruen
PM, Hernaíz Driever P, Budach V, Zips D, Grün
A.
Second
course of re-irradiation in pediatric diffuse intrinsic pontine
glioma : A case study.
Strahlenther
Onkol. 2023 Mar 2→.
doi: 10.1007/s00066-023-02057-x→.
PMID: 36862153→.
Case report. ˍ
|
|
|
|
Kaisman-Elbaz
T, Xiao T, Grabowski MM, Barnett GH, Mohammadi AM.
The
Impact of Extent of Ablation on Survival of Patients With Newly
Diagnosed Glioblastoma Treated With Laser Interstitial Thermal
Therapy: A Large Single-Institutional Cohort.
Neurosurgery.
2023 Mar 2→.
doi: 10.1227/neu.0000000000002430→.
PMID: 36861990→.
Observational study˰ ˍ
|
|
|
|
Riviere-Cazaux C, Lacey JM, Carlstrom LP, Laxen WJ,
Munoz-Casabella A, Hoplin MD, Ikram S, Zubair AB, Andersen KM,
Warrington AE, Decker PA, Kaufmann TJ, Campian JL, Eckel-Passow
JE, Kizilbash SH, Tortorelli S, Burns TC.
Cerebrospinal
fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for
IDH-mutant gliomas.
medRxiv
[Preprint]. 2023 Mar 2:2023.03.01.23286412→.
doi: 10.1101/2023.03.01.23286412→.
PMID: 36909488→.
Laboratory investigation. ˍ
|
|
|
|
Said MM, Broen MPG, Swart EL, Bartelink IH, Kouwenhoven
MCM.
Myelotoxicity of Temozolomide
Treatment in Patients with Glioblastoma Is It Time for a More
Mechanistic Approach?
Cancers (Basel). 2023 Mar
2;15(5):1561→.
doi: 10.3390/cancers15051561→.
PMID: 36900352→.
Editorial. ˍ
|
|
|
|
Azad TD,
Kalluri AL, Hansen LJ, Ammar A, Cohen AR.
H3
K27-altered diffuse midline glioma presenting as massive
cerebellopontine hemorrhage.
Childs
Nerv Syst. 2023 Mar 3→.
doi: 10.1007/s00381-023-05904-5→.
PMID: 36867241→.
Case report˰ ˍ
|
|
|
|
Gong M, Fan
X, Yu H, Niu W, Sun S, Wang H, Chen X.
Loss
of p53 Concurrent with RAS and TERT Activation Induces Glioma
Formation.
Mol
Neurobiol. 2023 Mar 3→.
doi: 10.1007/s12035-023-03288-w→.
PMID: 36867344→.
Laboratory investigation˰ ˍ
|
|
|
|
Schmidt S,
Kovacs E, Usta D, Behnisch R, Sahm F, Haux D, Witt O, Milde T,
Unterberg A, El Damaty A.
Cerebellar
mutism syndrome following posterior fossa tumor surgery in
children - a retrospective single center study.
World
Neurosurg. 2023 Mar 3:S1878-8750(23)00268-1→.
doi: 10.1016/j.wneu.2023.02.117→.
PMID: 36871657→.
Observational study˰ ˍ
|
|
|
|
Yao J, Li S, Cui Q, Ren Y, Li M, Wang J, Zeng M, Ji N, Peng Y,
Sessler DI.
Intraoperative hypotension
and postoperative stroke in older patients who had brain tumour
resections: a retrospective cohort analysis.
World
Neurosurg. 2023 Mar 4:S1878-8750(23)00284-X→.
doi: 10.1016/j.wneu.2023.02.136→.
PMID: 36878404→.
Observational study˰ ˍ
|
|
|
|
Łach K, Kowal A, Perek-Polnik M, Jakubczyk P, Arthur CJ, Bal
W, Drogosiewicz M, Dembowska-Bagińska B, Grajkowska W,
Cebulski J, Chaber R.
Infrared
Spectroscopy as a Potential Diagnostic Tool for
Medulloblastoma.
Molecules.
2023 Mar 5;28(5):2390→.
doi: 10.3390/molecules28052390→.
PMID: 36903631→.
Observational study. ˍ
|
|
|
|
Henriksen KA, Von Oettingen G, Skjøth-Rasmussen J,
Mathiasen R, Foss-Skiftesvik J.
Assessment
of the Milan Complexity Scale for prediction of postoperative
morbidity in pediatric neuro-oncological surgery.
Childs
Nerv Syst. 2023 Mar 6→.
doi: 10.1007/s00381-023-05902-7→.
PMID: 36877208→.
Observational study˰ ˍ
|
|
|
|
Jatana S, Mohammad AH, Al-Saadi TD, Carias M, Guevara-Moriones N,
Ruiz-Barrera MA, Mindru CS, Diaz RJ.
Characterization
of perioperative glycemic status and dexamethasone use with
associated postoperative complications in glioblastoma
patients.
Acta
Neurochir (Wien). 2023 Mar 6→.
doi: 10.1007/s00701-023-05541-6→.
PMID: 36879101→.
Observational study˰ ˍ
|
|
|
|
More S, Naiker T, Jacobs N, Oompie F, Prasad V.
Short-Interval,
Low-Dose [177Lu]Lu-Prostate-Specific Membrane Antigen in the
Treatment of Refractory Glioblastoma.
Clin
Nucl Med. 2023 Mar 6→.
doi: 10.1097/RLU.0000000000004612→.
PMID: 36881610→.
Case report˰ ˍ
|
|
|
|
Trifiletti DM, Akinyelu T, Burri SH, Jeudy A, Quinones-Hinojosa A,
Prabhu RS.
Glioma inadvertently treated
with preoperative stereotactic radiosurgery: focusing on safety.
J
Neurooncol. 2023 Mar 6→.
doi: 10.1007/s11060-023-04278-7→.
PMID: 36877383→.
Case report˰ ˍ
|
|
|
|
Ajuyah P, Mayoh C, Lau LMS, Barahona P, Wong M, Chambers H,
Valdes-Mora F, Senapati A, Gifford AJ, D'Arcy C, Hansford JR,
Manoharan N, Nicholls W, Williams MM, Wood PJ, Cowley MJ, Tyrrell
V, Haber M, Ekert PG, Ziegler DS, Khuong-Quang DA.
Histone
H3-wild type diffuse midline gliomas with H3K27me3 loss are a
distinct entity with exclusive EGFR or ACVR1 mutation and
differential methylation of homeobox genes.
Sci
Rep. 2023 Mar 7;13(1):3775→.
doi: 10.1038/s41598-023-30395-4→.
PMID: 36882456→.
Case report, Interventional study. ˍ
|
|
|
|
Friker LL, Tzaridis T, Enkirch SJ, Lüders C, Hattingen E,
Kristiansen G, Goschzik T, Waha A, Lütter C, Weller J,
Herrlinger U, Pietsch T, Gessi M, Baumert BG, Gielen
GH.
Gliosarcoma with extensive
extracranial metastatic spread and familial coincidence: A case
report.
Pathol
Res Pract. 2023 Mar 7;244:154399→.
doi: 10.1016/j.prp.2023.154399→.
PMID: 36905695→.
Case report˰ ˍ
|
|
|
|
Kaneoka A, Fujimoto SH, Tamura K, Inaji M, Maehara
T.
Nonconvulsive status epilepticus
characteristics in glioma patients: a retrospective study.
Discov
Oncol. 2023 Mar 7;14(1):30→.
doi: 10.1007/s12672-023-00632-3→.
PMID: 36881187→.
Observational
study. ˍ
|
|
|
|
Pace A, Belleudi V, Tanzilli A, Villani V, Poggi FR, Benincasa D,
Davoli M, Pinnarelli L.
Pattern of care
of brain tumor patients in the last months of life: analysis of a
cohort of 3045 patients in the last 10 years.
Neurol
Sci. 2023 Mar 7→.
doi: 10.1007/s10072-023-06722-y→.
PMID: 36882595→.
Observational study˰ ˍ
|
|
|
|
Kang Z, Li S, Lin Y, Li Y, Mao Y, Zhang J, Lei T, Wang H, Su Y,
Yang Y, Qiu J, Li W.
A phase I
dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in
patients with recurrent High-Grade Gliomas or Advanced Solid
Tumors.
Invest
New Drugs. 2023 Mar 8→.
doi: 10.1007/s10637-022-01325-4→.
PMID: 36884148→.
Interventional study. ˍ
|
|
|
|
Champeaux-Depond C, Jecko V, Weller J, Constantinou P, Tuppin P,
Metellus P.
Newly-diagnosed high grade
glioma surgery with carmustine wafers implantation. A long-term
nationwide retrospective study.
World
Neurosurg. 2023 Mar 10:S1878-8750(23)00311-X→.
doi: 10.1016/j.wneu.2023.03.015→.
PMID: 36906091→.
Observational study˰ ˍ
|
|
|
|
Fuentes-Fayos AC, G-García ME, Pérez-Gómez
JM, Montero-Hidalgo AJ, Martín-Colom J, Doval-Rosa C,
Blanco-Acevedo C, Torres E, Toledano-Delgado Á,
Sánchez-Sánchez R, Peralbo-Santaella E, Ortega-Salas
RM, Jiménez-Vacas JM, Tena-Sempere M, López M,
Castaño JP, Gahete MD, Solivera J, Luque RM.
Metformin
and simvastatin exert additive antitumour effects in glioblastoma
via senescence-state: clinical and translational
evidence.
EBioMedicine.
2023 Mar 10;90:104484→.
doi: 10.1016/j.ebiom.2023.104484→.
PMID: 36907105→.
Laboratory investigation, Observational study. ˍ
|
|
|
|
Shiba Y, Motomura K, Taniguchi R, Kurimoto M, Mizutani K, Ohka F,
Aoki K, Ito E, Nishikawa T, Yamaguchi J, Kibe Y, Shimizu H, Maeda
S, Nakashima T, Suzuki H, Muramatsu H, Takahashi Y, Saito
R.
Efficacy and safety of bevacizumab,
irinotecan, and temozolomide combination for relapsed or
refractory pediatric central nervous system embryonal tumor: a
single-institution study.
J
Neurosurg Pediatr. 2023 Mar 10:1-9→.
doi: 10.3171/2023.1.PEDS22345→.
PMID: 36905668→.
Observational study˰ ˍ
|
|
|
*
|
Hou Z, Wu H, Luo N, Li S, Zhang X, Dong S, Zhu D, Zhang H, Tao
R.
Almonertinib Combined with Anlotinib
and Temozolomide in a Patient with Recurrent Glioblastoma with
EGFR L858R Mutation.
Oncologist.
2023 Mar 13:oyac280→.
doi: 10.1093/oncolo/oyac280→.
PMID: 36913260→.
Case report. ˍ
|
|
|
|
Sharma M, McKenzie GW, Gaskins J, Yusuf M, Woo S, Mistry AM,
Williams BJ.
Demographic variations and
time to initiation of adjunct treatment following surgical
resection of anaplastic astrocytoma in the United States: a
National Cancer Database analysis.
J
Neurooncol. 2023 Mar 13→.
doi: 10.1007/s11060-023-04286-7?
PMID:
36913046→.
Observational study˰ ˍ
|
|
|
|
Pearl H, Fleischer CC.
Association
between altered metabolism and genetic mutations in human
glioma.
Cancer
Rep (Hoboken). 2023 Mar 14:e1799→.
doi: 10.1002/cnr2.1799→.
PMID: 36916606→.
Laboratory investigation. ˍ
|
|
|
|
Wu HW, Wu CH, Lin SC, Wu CC, Chen HH, Chen YW, Lee YY, Chang
FC.
MRI features of pediatric atypical
teratoid rhabdoid tumors and medulloblastomas of the posterior
fossa.
Cancer
Med. 2023 Mar 14→.
doi: 10.1002/cam4.5780→.
PMID: 36916326→.
Observational study. ˍ
|
|
|
|
|
|
|
|
|
